Experimental gel applied during surgery aims to boost cancer fight
NCT ID NCT06450106
Summary
This early-stage study is testing the safety of a new gel called STM-416p that is applied directly to the surgical area during prostate removal surgery. The gel is designed to help the body's immune system recognize and attack any remaining cancer cells after surgery. Researchers will enroll 18 men with prostate cancer to find the safest dose and check for side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Arizona Urology Specialists
RECRUITINGTucson, Arizona, 85715, United States
Contact Email: •••••@•••••
Contact
-
Australian Prostate Center
RECRUITINGMelbourne N., Victoria, 3051, Australia
Contact Email: •••••@•••••
Contact
-
Epworth HealthCare
RECRUITINGMelbourne N., Victoria, 3051, Australia
Contact Email: •••••@•••••
Contact
-
University of Florida
RECRUITINGGainesville, Florida, 32608, United States
Contact Email: •••••@•••••
Contact
Contact
Conditions
Explore the condition pages connected to this study.